Refine
Has Fulltext
- yes (131)
Is part of the Bibliography
- yes (131)
Year of publication
Document Type
- Journal article (125)
- Report (2)
- Conference Proceeding (1)
- Doctoral Thesis (1)
- Study Thesis (term paper) (1)
- Working Paper (1)
Keywords
- children (4)
- consortium (3)
- gene (3)
- ischemic stroke (3)
- magnetic resonance imaging (3)
- mouse (3)
- stroke (3)
- 4D flow (2)
- ADHD (2)
- COVID-19 (2)
- Candida albicans (2)
- Drosophila (2)
- Escherichia coli (2)
- Germany (2)
- Medizin (2)
- Mice (2)
- WSS (2)
- age (2)
- anxiety disorders (2)
- aortic arch (2)
- association (2)
- asthma (2)
- atherosclerosis (2)
- birth cohort (2)
- cardiac surgery (2)
- cells (2)
- common variants (2)
- disease (2)
- dopamine (2)
- epidemiology (2)
- factor XII (2)
- genetic modifiers (2)
- genetics (2)
- immunohistochemistry (2)
- in vivo imaging (2)
- incidence (2)
- infection (2)
- inflammation (2)
- investigators (2)
- longitudinal studies (2)
- macrophages (2)
- mental health (2)
- modifiers (2)
- ovarian cancer (2)
- oxidative stress (2)
- periodontitis (2)
- polymorphism (2)
- predictive markers (2)
- prognosis (2)
- prostate cancer (2)
- radial (2)
- risk (2)
- schizophrenia (2)
- single-nucleotide polymorphisms (2)
- systematic review (2)
- young children (2)
- 4D flow MRI (1)
- 5-fluorouracil (1)
- AKI (1)
- ALCL (1)
- APRI (1)
- ARDS (acute respiratory distress syndrome) (1)
- ARIA (1)
- ARPES (1)
- Actinoide (1)
- Acute osteomyelitis (1)
- Adrenocortical Carcinoma (1)
- Adults (1)
- Akutes Nierenversagen (1)
- Angle-resolved Photoemission Spectroscopy (1)
- Aortic arch (1)
- Aspergillus fumigatus (1)
- Asthma (1)
- B cells (1)
- BCR-ABL (1)
- BETA-Diversität (1)
- BETA-Multifunktionalität (1)
- BMP antagonist (1)
- BRCA1 (1)
- BRCA1/2 (1)
- BRCA2 (1)
- Bank credit (1)
- Bank-led Growth (1)
- Bessle functions (1)
- Beta-glucocerebrosidase (1)
- Bindungsverhältnisse (1)
- Biodiversität (1)
- Blood-brain barrier (1)
- Bombus Spp. Hymenoptera (1)
- Bor (1)
- Breast-tumors (1)
- CA4 (1)
- CARAT (1)
- CD3/19 depletion (1)
- CD34 selection (1)
- CD4\(^{+}\) T cells (1)
- CIS+ (1)
- CML (1)
- CMR (1)
- COMT (1)
- CRKL (1)
- CVID (1)
- Cardiovascular magnetic-resonance (1)
- Characterization and analytical techniques (1)
- China (1)
- Chronic rhino‑sinusitis (1)
- Coronary artery disease (1)
- Cyclooxygenase-2 (1)
- D insufficiency (1)
- D serum-levels (1)
- DNA (1)
- DNA methylation (1)
- DOPA-responsive-dystonia (1)
- Demyelinating peripheral neuropathy (1)
- Dendritische Zelle (1)
- Der p 23 (1)
- Dickkopf proteins (1)
- Dokumentationsqualität (1)
- EU-RHAB registry (1)
- Economic development (1)
- Economic growth (1)
- Entrepreneurship (1)
- Enzyme replacement therapy (1)
- Epilepsy (1)
- Europarecht (1)
- Europe (1)
- European Society for Immunodeficiencies (ESID) (1)
- F-19 MRI (1)
- FIB-4 (1)
- Fabry Disease (FD) (1)
- Finance (1)
- Finance-growth nexus (1)
- Forschungsstation Fabrikschleichach (1)
- Fruits (1)
- GATA-3 (1)
- GA\(^2\)LEN (1)
- GCH1 (1)
- GRAID (1)
- Gb3 and lyso-Gb3 biomarkers (1)
- Geldpolitik (1)
- Gene-expression (1)
- Genotype–phenotype correlations (1)
- German PID-NET registry (1)
- Guidelines (1)
- Guinea pig model (1)
- HBV (1)
- HE-3 diffusion MRI (1)
- HEV (1)
- Haematogenous (1)
- Hepatitis E (1)
- Heterocyclen (1)
- Histologic grade (1)
- Human behaviour (1)
- Hypertrophic cardiomyopathy (1)
- IL-12B (1)
- IL-12p40 (1)
- IL12B (1)
- IL28B polymorphisms (1)
- IgE (1)
- IgG substitution therapy (1)
- Images (1)
- Imaging techniques (1)
- Immunodeficiency (1)
- Immunstimulation (1)
- In-vivo (1)
- Industrial Policy (1)
- Industriepolitik (1)
- Inflammation (1)
- Innovationsforschung (1)
- Innovationsmanagement (1)
- Innovationspotenzial (1)
- Intensivtransport (1)
- Interhospitaltransfer (1)
- Interleukin-1 (1)
- Interleukin-4 (1)
- Internet of Things (1)
- Iron-oxide (1)
- Iron-uptake (1)
- KDIGO (1)
- Kartellrecht (1)
- Kartellverbot (1)
- LASP1 (1)
- LEED (1)
- LESA (1)
- LIMP-2 (1)
- LRP6 (1)
- Langzeitbeatmung (1)
- Lesions (1)
- Long bones (1)
- Lung cancer (1)
- Lungenkrebs (1)
- LyP (1)
- MASK (1)
- MRI reporter (1)
- Male breast cancer (1)
- Malignant effusion (1)
- Management (1)
- Manifestation (1)
- Mena/VASP (1)
- Meta‑analysis (1)
- Mexican coffee plantations (1)
- Molecular Physics (1)
- Molekülphysik (1)
- Mouse (1)
- Myc (1)
- Myc Transcription (1)
- Myocardial fibrosis (1)
- NA (1)
- NEIL2 (1)
- NF-κB/NFAT reporter cells (1)
- NMR spectroscopy (1)
- Neutral rate of interest (1)
- Northeastern Costa Rica (1)
- OGG1 (1)
- OPUS (1)
- OSI (1)
- Oncolytic virotherapy (1)
- Organisches Molekül (1)
- Osteomyelitis of the humerus (1)
- Ovarian (1)
- PID prevalence (1)
- PWV (1)
- Parkinson's disease (1)
- Particles (1)
- Partner für Innovation (1)
- Pathology (1)
- Personalized medicine (1)
- Phoenix dactylifera (1)
- Photoelektronenspektroskopie (1)
- Produktinnovation (1)
- Prognostic markers (1)
- Proteins (1)
- Psychiatric disorders (1)
- Querschnittsklausel (1)
- ROR1 (1)
- RTPS1 (1)
- RTPS2 (1)
- Raman micro-spectroscopy (1)
- Rats (1)
- Rituximab (1)
- SLC2A3 (1)
- Salmonella-typhimurium (1)
- Schlaganfall (1)
- Self-navigation (1)
- Soft-tissue infection (1)
- Sozialinnovation (1)
- Staphylococcus aureus (1)
- Strategic Emerging Industries (1)
- Sugar-transport (1)
- T cells (1)
- TCR (1)
- TGF-β superfamily (1)
- TIC disorders (1)
- Task force (1)
- Technische Innovation (1)
- Th17 (1)
- Therapy (1)
- Tracking (1)
- Tregs (1)
- United States (1)
- Universität (1)
- VEGF (1)
- Vascular endothelial Growth Factor (1)
- Vegetables (1)
- Ventricular-arrhythmias (1)
- WNT (1)
- Waldökosystem (1)
- Weaning (1)
- Wettbewerbsrecht (1)
- Winkelaufgelöste Photoemissionspektroskopie (1)
- Wirtschaft (1)
- Wirtschaftsentwicklung (1)
- Wirtschaftswachstum (1)
- Wnt signaling cascade (1)
- Würzburg (1)
- ZNF365 (1)
- Zins (1)
- \(\pi\)-Komplexe (1)
- abiotic stress (1)
- acinic cell carcinoma (1)
- acoustic radiation force impulse imaging (1)
- actin (1)
- acute kidney injury (1)
- acute lymphoblastic leukemia (1)
- adalimumab (1)
- adipose (1)
- adipose tissue dysfunction (1)
- aerobiology (1)
- agent-based model (1)
- aggregation (1)
- allergy (1)
- allogeneic stem cell transplantation (1)
- alveolar (1)
- amphotericin B (1)
- anaplastic large cell lymphoma (1)
- anastomotic leak (1)
- androgen deprivation therapy (1)
- animal physiology (1)
- anterior cingulate cortex (1)
- antibiotic resistance (1)
- antibiotics (1)
- antibodies (1)
- antidepressants (1)
- antigen (1)
- antimicrobial peptides (1)
- aorta (1)
- apoptosis (1)
- arteriitis temporal arteriitis (1)
- atrial fibrillation (1)
- attention‐deficit (1)
- atypical teratoid rhabdoid tumors (1)
- autism (1)
- autoantibodies (1)
- autoimmune disease (1)
- automated external defibrillators (1)
- bacterial cellulose dressing (1)
- bacterial pathogens (1)
- basal ganglia (1)
- bead models (1)
- beta diversity (1)
- beta-D-glucan (1)
- beta-lactamase inhibition (1)
- beta-multifunctionality (1)
- bile (1)
- binding analysis (1)
- biofilm formation (1)
- biological locomotion (1)
- biomaterial surfaces (1)
- biopharmaceuticals (1)
- bipolar disorder (1)
- bird species richness (1)
- blood coagulation (1)
- bohemian forest ecosystem (1)
- bone morphogenetic proteins (1)
- brain (1)
- brain asymmetry (1)
- brain laterality (1)
- brain tumor (1)
- breast cancer (1)
- bumblebee nest density (1)
- burden (1)
- c-reactive protein (1)
- cancer genomics (1)
- cancer immunotherapy (1)
- cardio-pulmonary resuscitation (1)
- cardiomyocyte proliferation (1)
- cardiopulmonary bypass (1)
- cardiovascular diseases (1)
- cell (1)
- cell binding assay (1)
- cell membranes (1)
- cell proliferation (1)
- cell therapy (1)
- chemerin (1)
- chemokines (1)
- chemotherapy (1)
- chest-compression rate (1)
- childhood (1)
- childhood asthma (1)
- chimeric antigen receptor (1)
- chip-seq (1)
- chromosomal aberration (1)
- chromosome 11Q13 (1)
- chronic Hepatitis C (1)
- cirrhosis (1)
- coagulation (1)
- cochlear implant (1)
- coding strategy (1)
- coherent anti-Stokes Raman scattering (CARS) microscopy (1)
- cohort studies (1)
- colorectal carcinoma (1)
- common SNPS (1)
- common genetic determinants (1)
- complex diseases (1)
- complication aortic-aneurysm (1)
- computational systems biology (1)
- correlation function (1)
- corticosteroid treatment (1)
- cross-sectional studies (1)
- cytokine (1)
- cytokine secretion (1)
- cytotoxic T cells (1)
- damage (1)
- data mining (1)
- data pool (1)
- data sharing (1)
- defense and evasion strategies (1)
- dendric cells (1)
- dendritic cells (1)
- density (1)
- dentate gyrus (1)
- dermatitis (1)
- developmental signaling (1)
- diabetes mellitus (1)
- differential expression (1)
- diffusion (1)
- digital phenotyping (1)
- digital transformation of health and care (1)
- dilated cardiomyopathy (1)
- diversity (1)
- documentation quality (1)
- dopaminergics (1)
- double-blind (1)
- down regulation (1)
- dual guidance (1)
- dung beetle coleoptera (1)
- early-life (1)
- ecological momentary assessment (1)
- economics (1)
- efficacy (1)
- electroencephalography (1)
- elements (1)
- emulsions (1)
- encryption (1)
- endoluminal (1)
- entrepreneurship (1)
- environmental monitoring (1)
- equilibrium real interest rate (1)
- erythrocyte sedimentation-rate (1)
- esophageal perforation (1)
- evolutionary genetics (1)
- exome sequencing (1)
- exposure therapy (1)
- expression (1)
- expression signature (1)
- extracranial malignant rhabdoid tumor (1)
- factor VIII (1)
- factor XI (1)
- family (1)
- family caregivers (1)
- fibrotest (1)
- field (1)
- field flow fractionation (1)
- filaggrin mutations (1)
- fine structure processing (1)
- fine-scale mapping (1)
- flow (1)
- flow dynamics (1)
- fluorescence imaging (1)
- fluorescence microscopy (1)
- fluorescence-detected sedimentation (1)
- fluorine (1)
- fluoroscopy (1)
- food allergy (1)
- food safety (1)
- forest ecosystem science (1)
- fungal disease (1)
- fungal pathogens (1)
- galactomannan (1)
- gastrointestinal perforation (1)
- gene expression (1)
- genetic interaction networks (1)
- genetic variants (1)
- genome-wide association (1)
- genomewide association (1)
- genomics (1)
- genotype-phenotype patterns (1)
- germline mutation (1)
- gilles (1)
- global change (1)
- graft-versus host (1)
- growth (1)
- habitat destruction (1)
- haplogroups (1)
- haplotypes (1)
- hay fever (1)
- heart (1)
- heme oxygenase-1 (1)
- hemorrhagic stroke (1)
- hepatitis C virus (1)
- high-risk hematology (1)
- hippocampus (1)
- histology (1)
- hospital exemption (1)
- hospitalizations (1)
- host-pathogen interaction (1)
- house dust mite allergy (1)
- human behaviour (1)
- human immune system (1)
- hydrodynamics (1)
- hyperactivity disorder (1)
- hyperpolarized HE-3 (1)
- hypertension (1)
- hypoxia-inducible factor 3A (1)
- ichthyology (1)
- illness (1)
- imaging (1)
- immune cells (1)
- immune evasion (1)
- immune reconstitution (1)
- immunological cross-talk (1)
- in vitro (1)
- in vivo experiments (1)
- in-hospital cardiac arrest (1)
- increases bone-formation (1)
- induced pluripotent stem cells (1)
- infarction (1)
- inflammatory diseases (1)
- influenza (1)
- informal caregiving (1)
- innovation (1)
- instensively managed farmland (1)
- intensified treatment (1)
- intensive care medicine (1)
- intensive care transport (1)
- interferon alpha (1)
- interhospital transfer (1)
- intracellular pathogens (1)
- isoprene (1)
- juvenile idiopathic arthritis (1)
- juvenile myoclonic epilepsy (1)
- kidney function (1)
- labor demand (1)
- labor market (1)
- land use (1)
- land-use change (1)
- large-vessel vasculitis (1)
- large‐scale data (1)
- library screening (1)
- ligand (1)
- linkage (1)
- live-attenuated influenza vaccine (1)
- liver diseases (1)
- liver resection (1)
- long-term ventilation (1)
- luciferase (1)
- lymph node metastases (1)
- lymphoid-tissue lymphomas (1)
- lymphoma (1)
- lymphomatoid papulosis (1)
- mRNA (1)
- magnetic susceptibility (1)
- magnetic-resonance behavior (1)
- magnetized sphere/cylinder (1)
- malt lymphoma (1)
- mapping (1)
- mapping susceptibility genes (1)
- memory B cells (1)
- mental disorders (1)
- mental illness (1)
- mesenchymal stromal cell (1)
- metanalysis (1)
- metastasis-directed therapy (1)
- methylation (1)
- mice (1)
- microscopy (1)
- missing heritability (1)
- mobile crowdsensing (1)
- mobile health (1)
- models (1)
- moisture balance (1)
- molecular neuroscience (1)
- monetary policy rules (1)
- mood disorders (1)
- morality (1)
- morphometry (1)
- mortality/survival (1)
- mucoepidermoid carcinoma (1)
- multilocularis (1)
- multiple diseases (1)
- multiple sclerosis (1)
- multiresistance (1)
- multivariate data analysis (1)
- multi‑center cohort study (1)
- music (1)
- myasthenia (1)
- negative pressure (1)
- neisseria gonorrhoeae (1)
- neonatal hypoxia (1)
- neonates (1)
- neuralgic amyotrophy (1)
- neurodegeneration (1)
- neurogenesis (1)
- neuroinflammation (1)
- neurological complications (1)
- neurology (1)
- neuron (1)
- neuronavigation (1)
- neuroprotection (1)
- neuropsychiatric disorders (1)
- nicht-wettbewerbliche Ziele (1)
- nilotinib (1)
- non competitive goals (1)
- non-invasive fibrosis assessment (1)
- non-triggered (1)
- number (1)
- obesity (1)
- observer agreement (1)
- ocular manifestations (1)
- oligmometastases (1)
- oligodendrocyte (1)
- oligorecurrence (1)
- oncogenesis (1)
- oncology (1)
- oncolytic viruses (1)
- onset (1)
- orosomucoid (1)
- osteoblasts (1)
- overweight (1)
- oxaliplatin (1)
- pH-regulated antigen 1 (Pra1) (1)
- paediatric cancer (1)
- paleoecology (1)
- palynology (1)
- pandemia (1)
- panic disorder (1)
- parotid gland (1)
- pathology (1)
- pedicle screws (1)
- pension reform (1)
- periodontal therapy (1)
- peroxisomes (1)
- persistence (1)
- personalized medicine (1)
- phase-contrast CMR (1)
- phosphates (1)
- phosphorylation (1)
- photosynthesis (1)
- physical activity (1)
- physical health (1)
- pili and fimbriae (1)
- pitch (1)
- plant community composition (1)
- plaque (1)
- plaque characteristics (1)
- plasminogen (1)
- pleomorphic adenoma (1)
- point shear wave elastography (1)
- pollination (1)
- polymorphisms (1)
- polymyalgia-rheomatica (1)
- poor prognosis (1)
- population (1)
- population-based studies (1)
- postmenopausal osteoporosis (1)
- postmortem (1)
- postoperativ (1)
- prefrontal cortex (1)
- preschool children (1)
- prevalence (1)
- primary biliary cholangitis (1)
- primary immunodeficiency (PID) (1)
- promoter (1)
- promoter methylation (1)
- prophylactic lithium (1)
- protein-protein recognition (1)
- proteins (1)
- proteomics (1)
- psychiatric disorders (1)
- public health (1)
- pulmonary aspergillosis (1)
- pulse wave velocity (1)
- pulse-wave velocity (1)
- quantification (1)
- radiation therapy (1)
- randomized controlled trial (1)
- rare diseases (1)
- rat (1)
- rat model (1)
- reaction time (1)
- reactivating p53 and inducing tumor apoptosis (RITA) (1)
- real-time PCR (1)
- receptor (1)
- recommendations (1)
- refractory aGvHD (1)
- register (1)
- registry for primary immunodeficiency (1)
- regression analysis (1)
- regulatory T cells (1)
- reliability (1)
- remote sensing (1)
- remote sensing‐enabled essential biodiversity variables (1)
- repair (1)
- repulsive guidance molecule A (1)
- research errors (1)
- resistance (1)
- retinol‐binding protein 4 (1)
- retrospective (1)
- retrospective study (1)
- rheumatoid arhritis (1)
- rhinitis (1)
- ribosome (1)
- risk factor (1)
- risk factors (1)
- rule discovery (1)
- salivary (1)
- sample (1)
- seasonal influenza (1)
- second line therapy (1)
- secondary wound dressing (1)
- secure group communication (1)
- selection (1)
- self-diffusion (1)
- self-employed (1)
- self-gating (1)
- self-navigation (1)
- sequence motif analysis (1)
- serum (1)
- severe fibrosis (1)
- signal inhibition (1)
- size exclusion chromatography (1)
- small business (1)
- snoRNA (1)
- spectrin (1)
- speech perception (1)
- spinco ultracentrifuge (1)
- spine (1)
- stereology (1)
- stereotactic body radiotherapy (1)
- steroid-resistant aGvHD (1)
- structural MRI (1)
- subphenotypes (1)
- subtypes (1)
- suppression (1)
- surgery (1)
- survival (1)
- survival analysis (1)
- susceptibility (1)
- susceptibility alleles (1)
- susceptibility loci (1)
- sustained virological response (1)
- symptoms (1)
- systemic and cutaneous CD30+ lymphoproliferations (1)
- systemic sclerosis (1)
- systemic vasculitides (1)
- team-training (1)
- telomere length (1)
- thymic epithelial tumor (1)
- thymitis (1)
- thymus (1)
- time trends (1)
- tocilizumab (IL-6 inhibitor) (1)
- transcription factor FOXP1 (1)
- transcription factor SPT5 (1)
- transient elastography (1)
- translational research (1)
- transmission (1)
- transmission model (1)
- transplantation (1)
- transverse relaxation (1)
- treatment guidelines (1)
- treatment response (1)
- troponin (1)
- tumor growth (1)
- tumors (1)
- urban-rural gradient (1)
- ursodeoxycholic acid (1)
- vaccination (1)
- vacuum-assisted closure (1)
- variants (1)
- vascular disease (1)
- velocity (1)
- vertebral pedicles (1)
- viral clearance (1)
- virus infection (1)
- von Willebrand type C domain (1)
- wall shear stress (1)
- weaning (1)
- wheeze (1)
- wound healing (1)
Institute
- Institut für Klinische Epidemiologie und Biometrie (18)
- Medizinische Klinik und Poliklinik II (17)
- Physikalisches Institut (15)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (14)
- Theodor-Boveri-Institut für Biowissenschaften (14)
- Medizinische Klinik und Poliklinik I (12)
- Institut für Humangenetik (10)
- Kinderklinik und Poliklinik (10)
- Neurologische Klinik und Poliklinik (9)
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (6)
Sonstige beteiligte Institutionen
- Clinical Trial Center (CTC) / Zentrale für Klinische Studien Würzburg (ZKSW) (2)
- Albert-Ludwigs-Universität Freiburg (1)
- Forschungsstation Fabrikschleichach (1)
- Genelux Corporation, San Diego Science Center, 3030 Bunker Hill Street, Suite 310, San Diego, California 92109, USA (1)
- Goethe-Universität Frankfurt (1)
- Leuphana Universität Lüneburg (1)
- MRB Forschungszentrum für Magnet-Resonanz-Bayern e.V., Am Hubland, D-97074 Würzburg (1)
- Technische Universität Dresden (1)
- Technische Universität München (1)
- Universität Bayreuth (1)
Analytical ultracentrifugation (AUC) is a first principles based method to determine absolute sedimentation coefficients and buoyant molar masses of macromolecules and their complexes, reporting on their size and shape in free solution. The purpose of this multi-laboratory study was to establish the precision and accuracy of basic data dimensions in AUC and validate previously proposed calibration techniques. Three kits of AUC cell assemblies containing radial and temperature calibration tools and a bovine serum albumin (BSA) reference sample were shared among 67 laboratories, generating 129 comprehensive data sets. These allowed for an assessment of many parameters of instrument performance, including accuracy of the reported scan time after the start of centrifugation, the accuracy of the temperature calibration, and the accuracy of the radial magnification. The range of sedimentation coefficients obtained for BSA monomer in different instruments and using different optical systems was from 3.655 S to 4.949 S, with a mean and standard deviation of (4.304\(\pm\)0.188) S (4.4%). After the combined application of correction factors derived from the external calibration references for elapsed time, scan velocity, temperature, and radial magnification, the range of s-values was reduced 7-fold with a mean of 4.325 S and a 6-fold reduced standard deviation of \(\pm\)0.030 S (0.7%). In addition, the large data set provided an opportunity to determine the instrument-to-instrument variation of the absolute radial positions reported in the scan files, the precision of photometric or refractometric signal magnitudes, and the precision of the calculated apparent molar mass of BSA monomer and the fraction of BSA dimers. These results highlight the necessity and effectiveness of independent calibration of basic AUC data dimensions for reliable quantitative studies.
Objective: The assessment of response to lithium maintenance treatment in bipolar disorder (BD) is complicated by variable length of treatment, unpredictable clinical course, and often inconsistent compliance. Prospective and retrospective methods of assessment of lithium response have been proposed in the literature. In this study we report the key phenotypic measures of the "Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder" scale currently used in the Consortium on Lithium Genetics (ConLiGen) study.
Materials and Methods: Twenty-nine ConLiGen sites took part in a two-stage case-vignette rating procedure to examine inter-rater agreement [Kappa (\(\kappa\))] and reliability [intra-class correlation coefficient (ICC)] of lithium response. Annotated first-round vignettes and rating guidelines were circulated to expert research clinicians for training purposes between the two stages. Further, we analyzed the distributional properties of the treatment response scores available for 1,308 patients using mixture modeling.
Results: Substantial and moderate agreement was shown across sites in the first and second sets of vignettes (\(\kappa\) = 0.66 and \(\kappa\) = 0.54, respectively), without significant improvement from training. However, definition of response using the A score as a quantitative trait and selecting cases with B criteria of 4 or less showed an improvement between the two stages (\(ICC_1 = 0.71\) and \(ICC_2 = 0.75\), respectively). Mixture modeling of score distribution indicated three subpopulations (full responders, partial responders, non responders).
Conclusions: We identified two definitions of lithium response, one dichotomous and the other continuous, with moderate to substantial inter-rater agreement and reliability. Accurate phenotypic measurement of lithium response is crucial for the ongoing ConLiGen pharmacogenomic study.
Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed.
Fanconi anemia (FA) is a genetically heterogeneous disorder with 22 disease-causing genes reported to date. In some FA genes, monoallelic mutations have been found to be associated with breast cancer risk, while the risk associations of others remain unknown. The gene for FA type C, FANCC, has been proposed as a breast cancer susceptibility gene based on epidemiological and sequencing studies. We used the Oncoarray project to genotype two truncating FANCC variants (p.R185X and p.R548X) in 64,760 breast cancer cases and 49,793 controls of European descent. FANCC mutations were observed in 25 cases (14 with p.R185X, 11 with p.R548X) and 26 controls (18 with p.R185X, 8 with p.R548X). There was no evidence of an association with the risk of breast cancer, neither overall (odds ratio 0.77, 95%CI 0.44–1.33, p = 0.4) nor by histology, hormone receptor status, age or family history. We conclude that the breast cancer risk association of these two FANCC variants, if any, is much smaller than for BRCA1, BRCA2 or PALB2 mutations. If this applies to all truncating variants in FANCC it would suggest there are differences between FA genes in their roles on breast cancer risk and demonstrates the merit of large consortia for clarifying risk associations of rare variants.
The direct estimation of heritability from genome-wide common variant data as implemented in the program Genome-wide Complex Trait Analysis (GCTA) has provided a means to quantify heritability attributable to all interrogated variants. We have quantified the variance in liability to disease explained by all SNPs for two phenotypically-related neurobehavioral disorders, obsessive-compulsive disorder (OCD) and Tourette Syndrome (TS), using GCTA. Our analysis yielded a heritability point estimate of 0.58 (se = 0.09, p = 5.64e-12) for TS, and 0.37 (se = 0.07, p = 1.5e-07) for OCD. In addition, we conducted multiple genomic partitioning analyses to identify genomic elements that concentrate this heritability. We examined genomic architectures of TS and OCD by chromosome, MAF bin, and functional annotations. In addition, we assessed heritability for early onset and adult onset OCD. Among other notable results, we found that SNPs with a minor allele frequency of less than 5% accounted for 21% of the TS heritability and 0% of the OCD heritability. Additionally, we identified a significant contribution to TS and OCD heritability by variants significantly associated with gene expression in two regions of the brain (parietal cortex and cerebellum) for which we had available expression quantitative trait loci (eQTLs). Finally we analyzed the genetic correlation between TS and OCD, revealing a genetic correlation of 0.41 (se = 0.15, p = 0.002). These results are very close to previous heritability estimates for TS and OCD based on twin and family studies, suggesting that very little, if any, heritability is truly missing (i.e., unassayed) from TS and OCD GWAS studies of common variation. The results also indicate that there is some genetic overlap between these two phenotypically-related neuropsychiatric disorders, but suggest that the two disorders have distinct genetic architectures.
Major depressive disorder and the anxiety disorders are highly prevalent, disabling and moderately heritable. Depression and anxiety are also highly comorbid and have a strong genetic correlation (r(g) approximate to 1). Cognitive behavioural therapy is a leading evidence-based treatment but has variable outcomes. Currently, there are no strong predictors of outcome. Therapygenetics research aims to identify genetic predictors of prognosis following therapy. We performed genome-wide association meta-analyses of symptoms following cognitive behavioural therapy in adults with anxiety disorders (n = 972), adults with major depressive disorder (n = 832) and children with anxiety disorders (n = 920; meta-analysis n = 2724). We (h(SNP)(2)) and polygenic scoring was used to examine genetic associations between therapy outcomes and psychopathology, personality and estimated the variance in therapy outcomes that could be explained by common genetic variants learning. No single nucleotide polymorphisms were strongly associated with treatment outcomes. No significant estimate of h(SNP)(2) could be obtained, suggesting the heritability of therapy outcome is smaller than our analysis was powered to detect. Polygenic scoring failed to detect genetic overlap between therapy outcome and psychopathology, personality or learning. This study is the largest therapygenetics study to date. Results are consistent with previous, similarly powered genome-wide association studies of complex traits.
Background: Alveolar echinococcosis (AE) is caused by the metacestode stage of Echinococcus multilocularis. Differential diagnosis with cystic echinococcosis (CE) caused by E. granulosus and AE is challenging. We aimed at improving diagnosis of AE on paraffin sections of infected human tissue by immunohistochemical testing of a specific antibody.
Methodology/Principal Findings: We have analysed 96 paraffin archived specimens, including 6 cutting needle biopsies and 3 fine needle aspirates, from patients with suspected AE or CE with the monoclonal antibody (mAb) Em2G11 specific for the Em2 antigen of E. multilocularis metacestodes. In human tissue, staining with mAb Em2G11 is highly specific for E. multilocularis metacestodes while no staining is detected in CE lesions. In addition, the antibody detects small particles of E. multilocularis (spems) of less than 1 mm outside the main lesion in necrotic tissue, liver sinusoids and lymphatic tissue most probably caused by shedding of parasitic material. The conventional histological diagnosis based on haematoxylin and eosin and PAS stainings were in accordance with the immunohistological diagnosis using mAb Em2G11 in 90 of 96 samples. In 6 samples conventional subtype diagnosis of echinococcosis had to be adjusted when revised by immunohistology with mAb Em2G11.
Conclusions/Significance: Immunohistochemistry with the mAb Em2G11 is a new, highly specific and sensitive diagnostic tool for AE. The staining of small particles of E. multilocularis (spems) outside the main lesion including immunocompetent tissue, such as lymph nodes, suggests a systemic effect on the host.
Background: Proportions of patients dying from the coronavirus disease-19 (COVID-19) vary between different countries. We report the characteristics; clinical course and outcome of patients requiring intensive care due to COVID-19 induced acute respiratory distress syndrome (ARDS).
Methods: This is a retrospective, observational multicentre study in five German secondary or tertiary care hospitals. All patients consecutively admitted to the intensive care unit (ICU) in any of the participating hospitals between March 12 and May 4, 2020 with a COVID-19 induced ARDS were included.
Results: A total of 106 ICU patients were treated for COVID-19 induced ARDS, whereas severe ARDS was present in the majority of cases. Survival of ICU treatment was 65.0%. Median duration of ICU treatment was 11 days; median duration of mechanical ventilation was 9 days. The majority of ICU treated patients (75.5%) did not receive any antiviral or anti-inflammatory therapies. Venovenous (vv) ECMO was utilized in 16.3%. ICU triage with population-level decision making was not necessary at any time. Univariate analysis associated older age, diabetes mellitus or a higher SOFA score on admission with non-survival during ICU stay.
Conclusions: A high level of care adhering to standard ARDS treatments lead to a good outcome in critically ill COVID-19 patients.
Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs.
Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel.
Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1-25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0-88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE-syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%-subcutaneous; 29%-intravenous; 1%-unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy.
Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment.
Background: Population-based data, which continuously monitors time trends in stroke epidemiology are limited. We investigated the incidence of pathological and etiological stroke subtypes over a 16 year time period. Methods: Data were collected within the Erlangen Stroke Project (ESPro), a prospective, population-based stroke register in Germany covering a total study population of 105,164 inhabitants (2010). Etiology of ischemic stroke was classified according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. Results: Between January 1995 and December 2010, 3,243 patients with first-ever stroke were documented. The median age was 75 and 55% were females. The total stroke incidence decreased over the 16 year study period in men (Incidence Rate Ratio 1995-1996 vs. 2009-2010 (IRR) 0.78; 95% CI 0.58-0.90) but not in women. Among stroke subtypes, a decrease in ischemic stroke incidence (IRR 0.73; 95% CI 0.57-0.93) and of large artery atherosclerotic stroke (IRR 0.27; 95% CI 0.12-0.59) was found in men and an increase of stroke due to small artery occlusion in women (IRR 2.33; 95% CI 1.39-3.90). Conclusions: Variations in time trends of pathological and etiological stroke subtypes were found between men and women that might be linked to gender differences in the development of major vascular risk factors in the study population.
INTRODUCTION:
The aim of this study was to evaluate the safety and efficacy of rituximab (RTX) in a large cohort of patients with rheumatoid arthritis in routine care, and to monitor changes in daily practice since the introduction of RTX therapy.
METHODS:
This was a multicentre, prospective, non-interventional study conducted under routine practice conditions in Germany. Efficacy was evaluated using Disease Activity Score in 28 joints (DAS28) and Health Assessment Questionnaire-Disability Index (HAQ-DI). Safety was assessed by recording adverse drug reactions (ADRs). Physician and patient global efficacy and tolerability assessments were also evaluated.
RESULTS:
Overall, 2,484 patients (76.7% female, mean age 56.4 years, mean disease duration 11.7 years) received RTX treatment (22.7% monotherapy). The total observation period was approximately six-years (median follow-up 14.7 months). RTX treatment led to improvements in DAS28 and HAQ-DI that were sustained over multiple courses. DAS28 improvements positively correlated with higher rheumatoid factor levels up to 50 IU/ml. Response and tolerability were rated good/very good by the majority of physicians and patients. Mean treatment intervals were 10.5 and 6.8 months for the first and last 400 enrolled patients, respectively. Infections were the most frequently reported ADRs (9.1%; 11.39/100 patient-years); approximately 1% of patients per course discontinued therapy due to ADRs.
CONCLUSIONS:
Prolonged RTX treatment in routine care is associated with good efficacy and tolerability, as measured by conventional parameters and by physicians' and patients' global assessments. Rheumatoid factor status served as a distinct and quantitative biomarker of RTX responsiveness. With growing experience, physicians repeated treatments earlier in patients with less severe disease activity.
Climate change is increasing the frequency and intensity of warming and drought periods around the globe, currently representing a threat to many plant species. Understanding the resistance and resilience of plants to climate change is, therefore, urgently needed. As date palm (Phoenix dactylifera) evolved adaptation mechanisms to a xeric environment and can tolerate large diurnal and seasonal temperature fluctuations, we studied the protein expression changes in leaves, volatile organic compound emissions, and photosynthesis in response to variable growth temperatures and soil water deprivation. Plants were grown under controlled environmental conditions of simulated Saudi Arabian summer and winter climates challenged with drought stress. We show that date palm is able to counteract the harsh conditions of the Arabian Peninsula by adjusting the abundances of proteins related to the photosynthetic machinery, abiotic stress and secondary metabolism. Under summer climate and water deprivation, these adjustments included efficient protein expression response mediated by heat shock proteins and the antioxidant system to counteract reactive oxygen species formation. Proteins related to secondary metabolism were downregulated, except for the P. dactylifera isoprene synthase (PdIspS), which was strongly upregulated in response to summer climate and drought. This study reports, for the first time, the identification and functional characterization of the gene encoding for PdIspS, allowing future analysis of isoprene functions in date palm under extreme environments. Overall, the current study shows that reprogramming of the leaf protein profiles confers the date palm heat- and drought tolerance. We conclude that the protein plasticity of date palm is an important mechanism of molecular adaptation to environmental fluctuations.
Immunological abnormalities associated with pathological conditions, such as higher infection rates, inflammatory diseases, cancer or cardiovascular events are common in patients with panic disorder. In the present study, T cell receptor excision circles (TRECs), Forkhead-Box-Protein P3 gene (FOXP3) methylation of regulatory T cells (Tregs) and relative telomere lengths (RTLs) were investigated in a total and subsamples of 131 patients with panic disorder as compared to 131 age- and sex-matched healthy controls in order to test for a potential dysfunction and premature aging of the immune system in anxiety disorders. Significantly lower TRECs (p = 0.004) as well as significant hypermethylation of the FOXP3 promoter region (p = 0.005) were observed in female (but not in male) patients with panic disorder as compared to healthy controls. No difference in relative telomere length was discerned between patients and controls, but significantly shorter telomeres in females, smokers and older persons within the patient group. The presently observed reduced TRECs in panic disorder patients and FOXP3 hypermethylation in female patients with panic disorder potentially reflect impaired thymus and immunosuppressive Treg function, which might partly account for the known increased morbidity and mortality of anxiety disorders conferred by e.g. cancer and cardiovascular disorders.
Multiple sclerosis (MS) is a prevalent neurological disease of complex etiology. Here, we describe the characterization of a multi-incident MS family that nominated a rare missense variant (p.G420D) in plasminogen (PLG) as a putative genetic risk factor for MS. Genotyping of PLG p.G420D (rs139071351) in 2160 MS patients, and 886 controls from Canada, identified 10 additional probands, two sporadic patients and one control with the variant. Segregation in families harboring the rs139071351 variant, identified p.G420D in 26 out of 30 family members diagnosed with MS, 14 unaffected parents, and 12 out of 30 family members not diagnosed with disease. Despite considerably reduced penetrance, linkage analysis supports cosegregation of PLG p.G420D and disease. Genotyping of PLG p.G420D in 14446 patients, and 8797 controls from Canada, France, Spain, Germany, Belgium, and Austria failed to identify significant association with disease (P = 0.117), despite an overall higher prevalence in patients (OR = 1.32; 95% CI = 0.93–1.87). To assess whether additional rare variants have an effect on MS risk, we sequenced PLG in 293 probands, and genotyped all rare variants in cases and controls. This analysis identified nine rare missense variants, and although three of them were exclusively observed in MS patients, segregation does not support pathogenicity. PLG is a plausible biological candidate for MS owing to its involvement in immune system response, blood-brain barrier permeability, and myelin degradation. Moreover, components of its activation cascade have been shown to present increased activity or expression in MS patients compared to controls; further studies are needed to clarify whether PLG is involved in MS susceptibility.
Background: Fruits and vegetables are rich in compounds with proposed antioxidant, anti-allergic and anti-inflammatory properties, which could contribute to reduce the prevalence of asthma and allergic diseases.
Objective: We investigated the association between asthma, and chronic rhino-sinusitis (CRS) with intake of fruits and vegetables in European adults.
Methods: A stratified random sample was drawn from the Global Allergy and Asthma Network of Excellence (GA\(^2\)LEN) screening survey, in which 55,000 adults aged 15–75 answered a questionnaire on respiratory symptoms. Asthma score (derived from self-reported asthma symptoms) and CRS were the outcomes of interest. Dietary intake of 22 subgroups of fruits and vegetables was ascertained using the internationally validated GA\(^2\)LEN Food Frequency Questionnaire. Adjusted associations were examined with negative binomial and multiple regressions. Simes procedure was used to control for multiple testing.
Results: A total of 3206 individuals had valid data on asthma and dietary exposures of interest. 22.8% reported having at least 1 asthma symptom (asthma score ≥1), whilst 19.5% had CRS. After adjustment for potential confounders, asthma score was negatively associated with intake of dried fruits (β-coefficient −2.34; 95% confidence interval [CI] −4.09, −0.59), whilst CRS was statistically negatively associated with total intake of fruits (OR 0.73; 95% CI 0.55, 0.97). Conversely, a positive association was observed between asthma score and alliums vegetables (adjusted β-coefficient 0.23; 95% CI 0.06, 0.40). None of these associations remained statistically significant after controlling for multiple testing.
Conclusion and clinical relevance: There was no consistent evidence for an association of asthma or CRS with fruit and vegetable intake in this representative sample of European adults.
(1) Background: Refractory acute graft-versus-host disease (R-aGvHD) remains a leading cause of death after allogeneic stem cell transplantation. Survival rates of 15% after four years are currently achieved; deaths are only in part due to aGvHD itself, but mostly due to adverse effects of R-aGvHD treatment with immunosuppressive agents as these predispose patients to opportunistic infections and loss of graft-versus-leukemia surveillance resulting in relapse. Mesenchymal stromal cells (MSC) from different tissues and those generated by various protocols have been proposed as a remedy for R-aGvHD but the enthusiasm raised by initial reports has not been ubiquitously reproduced. (2) Methods: We previously reported on a unique MSC product, which was generated from pooled bone marrow mononuclear cells of multiple third-party donors. The products showed dose-to-dose equipotency and greater immunosuppressive capacity than individually expanded MSCs from the same donors. This product, MSC-FFM, has entered clinical routine in Germany where it is licensed with a national hospital exemption authorization. We previously reported satisfying initial clinical outcomes, which we are now updating. The data were collected in our post-approval pharmacovigilance program, i.e., this is not a clinical study and the data is high-level and non-monitored. (3) Results: Follow-up for 92 recipients of MSC-FFM was reported, 88 with GvHD ≥°III, one-third only steroid-refractory and two-thirds therapy resistant (refractory to steroids plus ≥2 additional lines of treatment). A median of three doses of MSC-FFM was administered without apparent toxicity. Overall response rates were 82% and 81% at the first and last evaluation, respectively. At six months, the estimated overall survival was 64%, while the cumulative incidence of death from underlying disease was 3%. (4) Conclusions: MSC-FFM promises to be a safe and efficient treatment for severe R-aGvHD.
Opportunistic infections with the saprophytic yeast Candida albicans are a major cause of morbidity in immunocompromised patients. While the interaction of cells and molecules of innate immunity with C. albicans has been studied to great depth, comparatively little is known about the modulation of adaptive immunity by C. albicans. In particular, direct interaction of proteins secreted by C. albicans with CD4\(^{+}\) T cells has not been studied in detail. In a first screening approach, we identified the pH-regulated antigen 1 (Pra1) as a molecule capable of directly binding to mouse CD4\(^{+}\) T cells in vitro. Binding of Pra1 to the T cell surface was enhanced by extracellular Zn\(^{2+}\) ions which Pra1 is known to scavenge from the host in order to supply the fungus with Zn\(^{2+}\). In vitro stimulation assays using highly purified mouse CD4\(^{+}\) T cells showed that Pra1 increased proliferation of CD4\(^{+}\) T cells in the presence of plate-bound anti-CD3 monoclonal antibody. In contrast, secretion of effector cytokines such as IFNγ and TNF by CD4\(^{+}\) T cells upon anti-CD3/ anti-CD28 mAb as well as cognate antigen stimulation was reduced in the presence of Pra1. By secreting Pra1 C. albicans, thus, directly modulates and partially controls CD4\(^{+}\) T cell responses as shown in our in vitro assays.
Objectives: To assess the subjective and objective performance of the new fine structure processing strategy (FSP) compared to the previous generation coding strategies CIS+ and HDCIS. Methods: Forty-six adults with a minimum of 6 months of cochlear implant experience were included. CIS+, HDCIS and FSP were compared in speech perception tests in noise, pitch scaling and questionnaires. The randomized tests were performed acutely (interval 1) and again after 3 months of FSP experience (interval 3). The subjective evaluation included questionnaire 1 at intervals 1 and 3, and questionnaire 2 at interval 2, 1 month after interval 1. Results: Comparison between FSP and CIS+ showed that FSP performed at least as well as CIS+ in all speech perception tests, and outperformed CIS+ in vowel and monosyllabic word discrimination. Comparison between FSP and HDCIS showed that both performed equally well in all speech perception tests. Pitch scaling showed that FSP performed at least as well as HDCIS. With FSP, sound quality was at least as good and often better than with HDCIS. Conclusions: Results indicate that FSP performs better than CIS+ in vowel and monosyllabic word understanding. Subjective evaluation demonstrates strong user preferences for FSP when listening to speech and music.
Population-based genome wide association studies have identified a locus at 9p22.2 associated with ovarian cancer risk, which also modifies ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. We conducted fine-scale mapping at 9p22.2 to identify potential causal variants in BRCA1 and BRCA2 mutation carriers. Genotype data were available for 15,252 (2,462 ovarian cancer cases) BRCA1 and 8,211 (631 ovarian cancer cases) BRCA2 mutation carriers. Following genotype imputation, ovarian cancer associations were assessed for 4,873 and 5,020 SNPs in BRCA1 and BRCA 2 mutation carriers respectively, within a retrospective cohort analytical framework. In BRCA1 mutation carriers one set of eight correlated candidate causal variants for ovarian cancer risk modification was identified (top SNP rs10124837, HR: 0.73, 95%CI: 0.68 to 0.79, p-value 2× 10−16). These variants were located up to 20 kb upstream of BNC2. In BRCA2 mutation carriers one region, up to 45 kb upstream of BNC2, and containing 100 correlated SNPs was identified as candidate causal (top SNP rs62543585, HR: 0.69, 95%CI: 0.59 to 0.80, p-value 1.0 × 10−6). The candidate causal in BRCA1 mutation carriers did not include the strongest associated variant at this locus in the general population. In sum, we identified a set of candidate causal variants in a region that encompasses the BNC2 transcription start site. The ovarian cancer association at 9p22.2 may be mediated by different variants in BRCA1 mutation carriers and in the general population. Thus, potentially different mechanisms may underlie ovarian cancer risk for mutation carriers and the general population.
GTP cyclohydrolase 1, encoded by the GCH1 gene, is an essential enzyme for dopamine production in nigrostriatal cells. Loss-of-function mutations in GCH1 result in severe reduction of dopamine synthesis in nigrostriatal cells and are the most common cause of DOPA-responsive dystonia, a rare disease that classically presents in childhood with generalized dystonia and a dramatic long-lasting response to levodopa. We describe clinical, genetic and nigrostriatal dopaminergic imaging ([(123)I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) tropane single photon computed tomography) findings of four unrelated pedigrees with DOPA-responsive dystonia in which pathogenic GCH1 variants were identified in family members with adult-onset parkinsonism. Dopamine transporter imaging was abnormal in all parkinsonian patients, indicating Parkinson's disease-like nigrostriatal dopaminergic denervation. We subsequently explored the possibility that pathogenic GCH1 variants could contribute to the risk of developing Parkinson's disease, even in the absence of a family history for DOPA-responsive dystonia. The frequency of GCH1 variants was evaluated in whole-exome sequencing data of 1318 cases with Parkinson's disease and 5935 control subjects. Combining cases and controls, we identified a total of 11 different heterozygous GCH1 variants, all at low frequency. This list includes four pathogenic variants previously associated with DOPA-responsive dystonia (Q110X, V204I, K224R and M230I) and seven of undetermined clinical relevance (Q110E, T112A, A120S, D134G, I154V, R198Q and G217V). The frequency of GCH1 variants was significantly higher (Fisher's exact test P-value 0.0001) in cases (10/1318 = 0.75%) than in controls (6/5935 = 0.1%; odds ratio 7.5; 95% confidence interval 2.4-25.3). Our results show that rare GCH1 variants are associated with an increased risk for Parkinson's disease. These findings expand the clinical and biological relevance of GTP cycloydrolase 1 deficiency, suggesting that it not only leads to biochemical striatal dopamine depletion and DOPA-responsive dystonia, but also predisposes to nigrostriatal cell loss. Further insight into GCH1-associated pathogenetic mechanisms will shed light on the role of dopamine metabolism in nigral degeneration and Parkinson's disease.